Copyright © 2005 American Chemical Society
 

February 28, 2005 Issue

Volume 83, Issue 9
8309cov1Pfizer1
February 28, 2005 Issue, Vol. 83 | Iss. 9
High-tech tools and streamlined business processes are making their way to the far reaches of the drug development pipeline
By Rick Mullin, C&EN Northeast News Bureau
(pp. 29-39)
Features
Business
Swiss company's purchase of two firms will vault it into global leadership 
Science & Technology
Developing vaccines for seasonal and pandemic influenza is an ongoing challenge (pp. 49-56)
Back Issues
 

News of the Week

Novartis Tops Generics Market

Swiss company's purchase of two firms will vault it into global leadership
(p.11)

Capsuled Carbene

Transient intermediate is stabilized inside a cage at room temperature
(p.12)

Class-Action Suits Shifted

New law will move many of these large lawsuits into federal courts
(p.12)

MISTIC Boosts Protein Yields

Discovery allows eukaryotic membrane proteins to be made in high yields
(p.13)

EPA Sets Safe Dose For Perchlorate

Move will lead to new cleanup guidance for Superfund sites
(p.14)

Seaweeds Have An Appetite For TNT

Algae safely remove explosive compound from coastal marine environments
(p.14)

COX-2 HEARING

FDA panel leaves agency with tough decision on arthritis drugs
(p.15)
 

Departments

8309gov1_open_tifcxd

Government & Policy

Advisers recommend plan for EPA to rank submissions on high-production-volume chemicals
(pp. 42-43)
Mercury emissions controls may be installed by coal-fired utilities after decades of delay
(pp. 44-45)

Education

Committee on the Advancement of Women Chemists expands its programs for academics
(p.65)

Science & Technology

NEW SOFTWARE AND WEBSITES FOR THE CHEMICAL ENTERPRISE
(p.63)
Developing vaccines for seasonal and pandemic influenza is an ongoing challenge
(pp. 49-56)
Meeting highlights use of biophysical approaches in areas ranging from cell biology to glycobiology
(pp. 57-60)
Some are jaded about space exploration, but it's still worth getting excited about
(p.62)

Editor's Page

Letters

Letters(pp. 4-9)